medtech startup axio biosolutions secures n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Medtech startup Axio Biosolutions secures $7.4m funding from Ratan Tata PowerPoint Presentation
Download Presentation
Medtech startup Axio Biosolutions secures $7.4m funding from Ratan Tata

Loading in 2 Seconds...

play fullscreen
1 / 2

Medtech startup Axio Biosolutions secures $7.4m funding from Ratan Tata - PowerPoint PPT Presentation


  • 6 Views
  • Uploaded on

Read more about Medtech startup Axio Biosolutions secures $7.4m funding from Ratan Tata on Business Standard. MedTech is the first Indian company to launch an emergency haemostat for trauma care

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Medtech startup Axio Biosolutions secures $7.4m funding from Ratan Tata' - priya32438


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
medtech startup axio biosolutions secures

Medtech startup Axio Biosolutions secures

$7.4m funding from Ratan Tata

Medtech startup Axio Biosolutions raised $7.4 million funding in Series B round

from Ratan Tata's RNT Capital, which will be used for expansion to new markets,

and development of high-impact medical products.

The first Indian company to launch an emergency haemostat for trauma care,

Axio Biosolutions' flagship invention, Axiostat, is a patented and CE-approved

product that has prevented countless deaths due to haemorrhage and grievous

injuries.

The first-aid dressing stops uncontrollable bleeding within just 2-3 minutes of its

application, thus saving lives. Axiostat is the de-facto product of Indian armed

forces after being used in the surgical strike to save the lives of soldiers and is

now an essential part of their field kit. The product caters to the Indian Armed

forces bsf nsg para military forces hospitals

Forces, BSF, NSG, para-military forces, hospitals and emergency services in India

and across the globe.

"Uncontrolled bleeding is one of the leading causes of death from traumatic

injuries.

We are grateful to make a meaningful impact in this space by saving lives of

innocent victims. The current round of funding will help us expand into new

markets and introduce more products in the wound care and drug delivery

space", said Leo Mavely, Founder and CEO of Axio Biosolutions.

Headquartered in Boston, Axio Biosolutions has its corporate office in Bengaluru

and GMP-certified manufacturing facility in Gujarat. The company has built a

strong R&D structure, with multiple patents to its credit in the wound healing,

mucoadhesive drug delivery, and hemostats space.

Apart from the Tata emeritus, existing investors Accel Partners and IDG Ventures

India also participated in this round of funding.

Article By - Business Standard